ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,104,000 | -14.6% | 590,602 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $1,293,000 | -34.5% | 590,602 | 0.0% | 0.02% | -34.6% |
| Q3 2021 | $1,973,000 | +25.1% | 590,602 | 0.0% | 0.03% | +23.8% |
| Q2 2021 | $1,577,000 | +24.8% | 590,602 | 0.0% | 0.02% | +10.5% |
| Q1 2021 | $1,264,000 | -38.8% | 590,602 | -32.9% | 0.02% | -40.6% |
| Q4 2020 | $2,064,000 | +21.1% | 879,541 | 0.0% | 0.03% | -3.0% |
| Q3 2020 | $1,705,000 | -31.1% | 879,541 | 0.0% | 0.03% | -38.9% |
| Q2 2020 | $2,473,000 | +16.0% | 879,541 | 0.0% | 0.05% | -21.7% |
| Q1 2020 | $2,131,000 | -50.4% | 879,541 | 0.0% | 0.07% | -43.0% |
| Q4 2019 | $4,300,000 | +87.9% | 879,541 | +124.1% | 0.12% | +59.2% |
| Q3 2019 | $2,288,000 | -58.5% | 392,513 | -55.4% | 0.08% | -54.8% |
| Q2 2019 | $5,516,000 | -4.5% | 879,541 | 0.0% | 0.17% | -15.6% |
| Q1 2019 | $5,776,000 | +65.9% | 879,541 | 0.0% | 0.20% | +29.2% |
| Q4 2018 | $3,481,000 | -57.2% | 879,541 | +13.8% | 0.15% | -48.5% |
| Q3 2018 | $8,140,000 | – | 772,556 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,349,953 | $8,707,000 | 2.23% |
| Novo Holdings A/S | 2,181,843 | $14,073,000 | 1.97% |
| Sofinnova Investments, Inc. | 1,180,178 | $7,612,000 | 0.70% |
| Eventide Asset Management | 879,541 | $5,516,000 | 0.17% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,020,748 | $6,584,000 | 0.10% |
| Blackstone Inc. | 1,623,405 | $10,471,000 | 0.06% |
| Granahan Investment Management | 138,541 | $894,000 | 0.04% |
| Janney Montgomery Scott LLC | 44,917 | $290,000 | 0.00% |
| OneDigital Investment Advisors LLC | 1,510 | $10,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,457 | $9,000 | 0.00% |